Article
Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease.
Department of Neurology and Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA.
Nature medicine (impact factor:
27.14).
06/2011;
17(6):673-5.
DOI:10.1038/nm.2389
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Immunoregulation in cutaneous allergy: prevention and control.
[show abstract] [hide abstract]
ABSTRACT: The cutaneous surface is exposed to a myriad of encounters with chemicals, allergens and microbes. Nevertheless, it withstands these environmental assaults without overt inflammation. We will discuss the role of T regulatory cells in a situation where this tissue homeostasis fails - cutaneous allergy, in particular contact hypersensitivity. Immune regulation is a complex process that is mediated by many cellular players. T regulatory cells have risen to particular prominence as potent immunosuppressors because their absence results in inflammation including skin allergy. Recent findings revealed that T regulatory cells comprise a heterogeneous group of subpopulations with specialized homing capabilities and suppressor functions. The stability of the T regulatory cell subset in proinflammatory microenvironments is controversially discussed. In addition, it has recently been shown that mechanisms by which T regulatory cells exert their immunosuppressive functions can be adopted by pathogenic effector T cells in certain situations. In cutaneous allergy, immunoregulatory mechanisms are dysfunctional. The cellular players comprise classical T regulatory cells as well as effector T cells with regulatory activities. Understanding their role in skin homeostasis and the mechanisms by which their regulatory functions are abrogated will yield novel therapeutic targets for the treatment of cutaneous allergies.Current Opinion in Allergy and Clinical Immunology 07/2012; 12(5):498-503. · 4.11 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
cultured
functional plasticity
healthy control individuals
healthy control subjects
healthy subjects
human T(reg)
IFN-β
IFN-γ)-secreting Foxp3(+
IFN-γ-specific antibodies
interferon-γ
interleukin-12
relapsing remitting multiple sclerosis
suppressive activity
T helper type 1
T(H)1-like phenotype
untreated subjects
vitro